about
Kinetics of avibactam inhibition against Class A, C, and D β-lactamasesNew Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including BiofilmsInterferon-Free Treatments for Chronic Hepatitis C Genotype 1 InfectionNew β-Lactamase Inhibitors in the ClinicLaboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden ThreatThe β-Lactams Strike Back: Ceftazidime-AvibactamStrategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infectionsAntibiotic adjuvants: identification and clinical useStrategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosisBoron chemicals in diagnosis and therapeuticsDesign, Synthesis, and Crystal Structures of 6-Alkylidene-2′-Substituted Penicillanic Acid Sulfones as Potent Inhibitors of Acinetobacter baumannii OXA-24 CarbapenemaseDesign, Synthesis, Crystal Structures, and Antimicrobial Activity of Sulfonamide Boronic Acids as β-Lactamase InhibitorsStructures of the Michaelis Complex (1.2 Å) and the Covalent Acyl Intermediate (2.0 Å) of Cefamandole Bound in the Active Sites of the Mycobacterium tuberculosis β-Lactamase K73A and E166A Mutants,Novel Insights into the Mode of Inhibition of Class A SHV-1 -Lactamases Revealed by Boronic Acid Transition State InhibitorsA kinked antimicrobial peptide from Bombina maxima. I. Three-dimensional structure determined by NMR in membrane-mimicking environmentsIncreased Structural Flexibility at the Active Site of a Fluorophore-conjugated -Lactamase Distinctively Impacts Its Binding toward Diverse Cephalosporin AntibioticsAnalysis of the Binding Forces Driving the Tight Interactions between -Lactamase Inhibitory Protein-II (BLIP-II) and Class A -LactamasesCrystal Structure of a Preacylation Complex of the β-Lactamase Inhibitor Sulbactam Bound to a Sulfenamide Bond-Containing Thiol-β-lactamaseStructure of Apo- and Monometalated Forms of NDM-1—A Highly Potent Carbapenem-Hydrolyzing Metallo-β-LactamaseFragment-guided design of subnanomolar -lactamase inhibitors active in vivoGES-18, a New Carbapenem-Hydrolyzing GES-Type -Lactamase from Pseudomonas aeruginosa That Contains Ile80 and Ser170 ResiduesStructures of SHV-1 β-Lactamase with Penem and Penam Sulfone Inhibitors That Form Cyclic Intermediates Stabilized by Carbonyl ConjugationDesign and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-LactamaseA neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferaseStructure of New Delhi metallo-β-lactamase 1 (NDM-1)Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC -LactamasesInhibition of dd -Peptidases by a Specific Trifluoroketone: Crystal Structure of a Complex with the Actinomadura R39 dd -PeptidaseCrystal Structures of KPC-2 -Lactamase in Complex with 3-Nitrophenyl Boronic Acid and the Penam Sulfone PSR-3-226Rational Design of Fatty Acid Amide Hydrolase Inhibitors That Act by Covalently Bonding to Two Active Site ResiduesCrystal structure of L,D-transpeptidase LdtMt2 in complex with meropenem reveals the mechanism of carbapenem against Mycobacterium tuberculosisInsights into -Lactamases from Burkholderia Species, Two Phylogenetically Related yet Distinct Resistance DeterminantsThe Importance of thetrans-Enamine Intermediate as a β-Lactamase Inhibition Strategy Probed in Inhibitor-Resistant SHV β-Lactamase VariantsRestoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibioticsStructure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistanceSolution structures of the Bacillus cereus metallo-β-lactamase BcII and its complex with the broad spectrum inhibitor R -thiomandelic acidCan Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis -Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of -Lactam- -Lactamase Inhibitor CombinationsPenam Sulfones and β-Lactamase Inhibition: SA2-13 and the Importance of the C2 Side Chain Length and CompositionCrystal Structure of the Carbapenem Intrinsic Resistance Protein CarGTargeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid DerivativeStructural and biochemical characterization of VIM-26 shows that Leu224 has implications for the substrate specificity of VIM metallo-β-lactamases
P2860
Q24617763-9167DFF6-97CE-4890-8E75-E01DB1C71FC2Q26741342-E0AE7748-8E93-4D78-AA50-B9EAE07394F6Q26746563-6739E104-7EAA-4DD6-852D-7A17DC248C43Q26747150-0A00EAFC-5468-4F2A-9559-E67C94D139C7Q26751295-777C7A54-22E2-42BF-95D3-DEC98531E96FQ26796425-ADDA571E-DAAC-4229-9311-15DFE91886DDQ26859978-483D565E-34BF-48FA-8528-9D1C5BF79FEDQ26998687-102A75D8-EFD3-49C9-BABC-3149C5A500AAQ27003186-0A52116C-F247-402B-ADB4-51AE5FF5BBB4Q27006075-3CE34D69-CFE9-4E6F-9EE9-DF8FFA5855FFQ27664292-88C1D562-40DA-45FC-88B6-1B232B1B4377Q27665021-B6A65934-BA08-41B4-B776-06FC58484D65Q27665220-6B9EF447-3F09-4D6A-BF9B-20776E067EF3Q27665516-90BF764B-E445-47C6-82B0-FF25E2DD8015Q27666507-ADFA8D8F-67FC-448D-B47B-E5F521830B2EQ27670555-77C5EA1B-CE55-4761-8EF5-B5BC0E6E0D4BQ27670891-169AF95C-C87E-477E-A650-7B56EEA46EB9Q27673054-9B579EBD-A74B-4F36-9D13-151A73847DC8Q27674309-4D338001-824C-4BCE-A3C6-422CDCAB568DQ27674310-7107E209-64A6-4D58-A6AA-1C4E9D66E7DDQ27674861-0C17D4BF-8F1E-4DA5-AB18-40492B085C6EQ27675092-A47E1170-473E-4CAF-B984-32EF8C1EA986Q27675536-395BAC89-1414-4823-9598-24B90BB3A072Q27675565-5932680C-2FEA-4357-9AF9-1469F055D43FQ27675680-C4B8F44B-0D18-4A8E-96F3-63DAAA6B4F3FQ27676626-CE863B35-6939-464F-957B-E9C8DEB71679Q27676788-664E836E-72A6-4B67-89AF-D1DD81398491Q27677247-2AB33684-C440-4534-B0C4-6794768BD5D7Q27677344-42C85B5A-02BA-4445-8E36-CDD22B204F34Q27677374-4828FD36-54E9-4A14-94D0-58C4C9459DA4Q27678056-0A4C858C-09DF-4E86-ADE6-A5A174CC9628Q27678147-62C6F23A-7270-48F0-A03A-C2E770B365D4Q27678160-54B99826-DDB5-47B7-8DBE-A5358BDACD36Q27678586-ADCCDDEC-F636-46D1-8466-30C78B7BC893Q27680023-F0B358A0-A823-4750-9C34-EA7C602D92FAQ27680025-8937BB7F-7F4F-40B7-88D4-51D28782BDC6Q27681435-9E092ED1-3ED5-4166-982E-5D32FC0F701FQ27681932-D422DACA-992C-4145-95C0-B293A4D5FCFEQ27684016-D7B5688D-CDC4-4860-820F-2BC6FC6F99DCQ27697590-2A15342B-6176-4E20-8054-377154C498BB
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Three decades of beta-lactamase inhibitors
@ast
Three decades of beta-lactamase inhibitors
@en
Three decades of beta-lactamase inhibitors
@nl
type
label
Three decades of beta-lactamase inhibitors
@ast
Three decades of beta-lactamase inhibitors
@en
Three decades of beta-lactamase inhibitors
@nl
prefLabel
Three decades of beta-lactamase inhibitors
@ast
Three decades of beta-lactamase inhibitors
@en
Three decades of beta-lactamase inhibitors
@nl
P2860
P3181
P356
P1476
Three decades of beta-lactamase inhibitors
@en
P2093
Sarah M Drawz
P2860
P304
P3181
P356
10.1128/CMR.00037-09
P407
P577
2010-01-01T00:00:00Z